Immunology of hepatitis B virus and hepatitis C virus infection (original) (raw)

• Fattovich, G. Natural history and prognosis of hepatitis B. Semin. Liver Dis. 23, 47–58 (2003).
  PubMed Google Scholar
• Seeff, L. B. Natural history of chronic hepatitis C. Hepatology 36, S35–S36 (2002).
  PubMed Google Scholar
• Candotti, D., Temple, J., Sarkodie, F. & Allain, J. P. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J. Virol. 77, 7914–7923 (2003).
  CAS PubMed PubMed Central Google Scholar
• Guidotti, L. G. et al. Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825–829 (1999). This study shows that non-cytolytic, cytokine-mediated clearance of HBV from infected hepatocytes occurs during acute HBV infection of non-human primates.
  CAS PubMed Google Scholar
• Thimme, R. et al. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77, 68–76 (2003).
  CAS PubMed PubMed Central Google Scholar
• Kolykhalov, A. et al. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277, 570–574 (1997).
  CAS PubMed Google Scholar
• Yanagi, M., Purcell, R. H., Emerson, S. U. & Bukh, J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl Acad. Sci. USA 94, 8738–8743 (1997).
  CAS PubMed PubMed Central Google Scholar
• Bassett, S. E., Brasky, K. M. & Lanford, R. E. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J. Virol. 72, 2589–2599 (1998).
  CAS PubMed PubMed Central Google Scholar
• Nascimbeni, M. et al. Kinetics of CD4+ and CD8+ memory T cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J. Virol. 77, 4781–4793 (2003).
  CAS PubMed PubMed Central Google Scholar
• Bigger, C. B., Brasky, K. M. & Lanford, R. E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75, 7059–7066 (2001).
  CAS PubMed PubMed Central Google Scholar
• Lanford, R. E. et al. Cross-genotype immunity to hepatitis C virus. J. Virol. 78, 1575–1581 (2004).
  CAS PubMed PubMed Central Google Scholar
• Shoukry, N. et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197, 1645–1655 (2003). This paper highlights the importance of memory CD8+ T cells in the control of HCV infection. In vivo depletion of this T-cell subset from chimpanzees that have previously recovered from HCV abrogates protective immunity on rechallenge with HCV.
  CAS PubMed PubMed Central Google Scholar
• Grakoui, A. et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659–662 (2003). An important study showing that in vivo depletion of CD4+ T cells from chimpanzees that have previously recovered from HCV abrogates protective immunity and results in persistent HCV infection on rechallenge.
  CAS PubMed Google Scholar
• Logvinoff, C. et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl Acad. Sci. USA 101, 10149–10154 (2004). In this study, infectious retroviral pseudotypes that express HCV envelope glycoproteins were used to screen sera for the presence of neutralizing antibodies. The titre of pseudotype-neutralizing antibodies increase late during the course of chronic hepatitis C.
  CAS PubMed PubMed Central Google Scholar
• Thimme, R. et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl Acad. Sci. USA 99, 15661–15668 (2002).
  CAS PubMed PubMed Central Google Scholar
• Ganem, D. & Schneider, R. J. in Fields Virology Vol. 2 (eds Knipe, D. et al.) 2923–2969 (Lippincott Williams & Wilkins, Philadelphia, 2001).
  Google Scholar
• Guidotti, L. G., Matzke, B., Schaller, H. & Chisari, F. V. High-level hepatitis B virus replication in transgenic mice. J. Virol. 69, 6158–6169 (1995).
  CAS PubMed PubMed Central Google Scholar
• Bukh, J., Apgar, C. L. & Yanagi, M. Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB virus-B hepatitis agent. Virology 262, 470–478 (1999).
  CAS PubMed Google Scholar
• Lohmann, V. et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110–113 (1999). The first report to show a subgenomic HCV replicon in a human hepatoma cell line.
  Article CAS PubMed Google Scholar
• Blight, K. J., Kolykhalov, A. A. & Rice, C. M. Efficient initiation of HCV RNA replication in cell culture. Science 290, 1972–1974 (2000). This studies identifies multiple adaptive mutations that confer increased replicative ability to subgenomic HCV replicons in vitro.
  CAS PubMed Google Scholar
• Bartosch, B., Dubuisson, J. & Cosset, F. L. Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes. J. Exp. Med. 197, 633–642 (2003).
  CAS PubMed PubMed Central Google Scholar
• McKeating, J. A. et al. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J. Virol. 78, 8496–8505 (2004).
  CAS PubMed PubMed Central Google Scholar
• Heller, T. et al. An in vitro model of hepatitis C virion production. Proc. Natl Acad. Sci. USA 102, 2579–2583 (2005).
  CAS PubMed PubMed Central Google Scholar
• Lindenbach, B. D. & Rice, C. M. in Fields Virology Vol. 1 (eds Knipe, D. et al.) 991–1041 (Lippincott Williams & Wilkins, Philadelphia, 2001).
  Google Scholar
• Egger, D. et al. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76, 5974–5984 (2002).
  CAS PubMed PubMed Central Google Scholar
• Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395–1406 (2001).
  CAS PubMed PubMed Central Google Scholar
• Major, M. E. et al. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 39, 1709–1720 (2004).
  PubMed Google Scholar
• Gerlach, J. T. et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 117, 933–941 (1999).
  CAS PubMed Google Scholar
• Pham, T. N. et al. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J. Virol. 78, 5867–5874 (2004).
  CAS PubMed PubMed Central Google Scholar
• Takaki, A. et al. Cellular immune responses persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C. Nature Med. 6, 578–582 (2000). This study shows that HCV-specific antibodies decrease to undetectable levels 10–20 years after spontaneous clinical recovery from a single-source outbreak of HCV, whereas HCV-specific T-cell responses are maintained.
  CAS PubMed Google Scholar
• Seeff, L. B. et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 33, 455–463 (2001).
  CAS PubMed Google Scholar
• Wieland, S., Thimme, R., Purcell, R. H. & Chisari, F. V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl Acad. Sci. USA 101, 6669–6674 (2004).
  CAS PubMed PubMed Central Google Scholar
• Su, A. I. et al. Genomic analysis of the host response to hepatitis C virus infection. Proc. Natl Acad. Sci. USA 99, 15669–15674 (2002).
  CAS PubMed PubMed Central Google Scholar
• McClary, H., Koch, R., Chisari, F. V. & Guidotti, L. G. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74, 2255–2264 (2000).
  CAS PubMed PubMed Central Google Scholar
• Wieland, S. F., Guidotti, L. G. & Chisari, F. V. Intrahepatic induction of α/β interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J. Virol. 74, 4165–4173 (2000).
  CAS PubMed PubMed Central Google Scholar
• Guidotti, L. G. et al. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J. Virol. 76, 2617–2621 (2002).
  CAS PubMed PubMed Central Google Scholar
• Robek, M. D., Wieland, S. F. & Chisari, F. V. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J. Virol. 76, 3570–3574 (2002).
  CAS PubMed PubMed Central Google Scholar
• Kakimi, K., Lane, T. E., Chisari, F. V. & Guidotti, L. G. Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J. Immunol. 167, 6701–6705 (2001).
  CAS PubMed Google Scholar
• Baron, J. L. et al. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583–594 (2002).
  CAS PubMed Google Scholar
• Guidotti, L. G. et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25–36 (1996).
  CAS PubMed Google Scholar
• Fitzgerald, K. A. et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nature Immunol. 4, 491–496 (2003).
  CAS Google Scholar
• Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunol. 5, 730–737 (2004).
  CAS Google Scholar
• Balachandran, S., Thomas, E. & Barber, G. N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432, 401–405 (2004).
  CAS PubMed Google Scholar
• Frese, M., Pietschmann, T., Moradpour, D., Haller, O. & Bartenschlager, R. Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J. Gen. Virol. 82, 723–733 (2001).
  CAS PubMed Google Scholar
• Foy, E. et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300, 1145–1148 (2003).
  CAS PubMed Google Scholar
• Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N. & Lai, M. M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285, 107–110 (1999).
  CAS PubMed Google Scholar
• Gale, M. J. Jr et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217–227 (1997).
  CAS PubMed Google Scholar
• Taylor, D. R., Shi, S. T. & Lai, M. M. Hepatitis C virus and interferon resistance. Microbes Infect. 2, 1743–1756 (2000).
  CAS PubMed Google Scholar
• Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872–874 (2004).
  CAS PubMed Google Scholar
• Crotta, S. et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35–42 (2002).
  CAS PubMed PubMed Central Google Scholar
• Tseng, C. T. & Klimpel, G. R. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med. 195, 43–49 (2002).
  CAS PubMed PubMed Central Google Scholar
• Jinushi, M. et al. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 173, 6072–6081 (2004).
  CAS PubMed Google Scholar
• Ferrari, C. et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145, 3442–3449 (1990).
  CAS PubMed Google Scholar
• Rehermann, B. et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181, 1047–1058 (1995).
  CAS PubMed Google Scholar
• Wedemeyer, H. et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169, 3447–3458 (2002).
  CAS PubMed Google Scholar
• Diepolder, H. M. et al. Possible mechanism involving T lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006–1007 (1995). The first study to show that vigorous HCV-specific T-cell responses are associated with recovery from acute hepatitis C.
  CAS PubMed Google Scholar
• Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499–1512 (2000).
  CAS PubMed PubMed Central Google Scholar
• Crispe, I. N. Hepatic T cells and liver tolerance. Nature Rev. Immunol. 3, 51–62 (2003).
  CAS Google Scholar
• Guidotti, L. G. et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl Acad. Sci. USA 93, 4589–4594 (1996).
  CAS PubMed PubMed Central Google Scholar
• Pasquetto, V., Guidotti, L. G., Kakimi, K., Tsuji, M. & Chisari, F. V. Host–virus interactions during malaria infection in hepatitis B virus transgenic mice. J. Exp. Med. 192, 529–536 (2000).
  CAS PubMed PubMed Central Google Scholar
• Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921–930 (2000).
  CAS PubMed PubMed Central Google Scholar
• Tsui, L. V., Guidotti, L. G., Ishikawa, T. & Chisari, F. V. Post-transcriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte activated hepatocytes. Proc. Natl Acad. Sci. USA 92, 12398–12402 (1995).
  CAS PubMed PubMed Central Google Scholar
• Heise, T., Guidotti, L. G. & Chisari, F. V. Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J. Virol. 75, 6874–6883 (2001).
  CAS PubMed PubMed Central Google Scholar
• Guidotti, L. G., McClary, H., Loudis, J. M. & Chisari, F. V. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J. Exp. Med. 191, 1247–1252 (2000).
  CAS PubMed PubMed Central Google Scholar
• Gerlach, J. T. et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125, 80–88 (2003).
  PubMed Google Scholar
• Cooper, S. et al. Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439–449 (1999).
  CAS PubMed Google Scholar
• Cheney, I. W. et al. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by α, β, and γ interferons. J. Virol. 76, 11148–11154 (2002).
  CAS PubMed PubMed Central Google Scholar
• Urbani, S. et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J. Virol. 76, 12423–12434 (2002).
  CAS PubMed PubMed Central Google Scholar
• Chen, M. et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 116, 135–143 (1999).
  CAS PubMed Google Scholar
• Maruyama, T. et al. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 91, 2586–2595 (1993).
  CAS PubMed PubMed Central Google Scholar
• Farci, P. et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl Acad. Sci. USA 91, 7792–7796 (1994). The first study to show neutralization of in vivo infectivity of HCV by specific antibodies.
  CAS PubMed PubMed Central Google Scholar
• Forns, X. et al. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 32, 618–625 (2000).
  CAS PubMed Google Scholar
• Baumert, T. F. et al. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 32, 610–617 (2000).
  CAS PubMed Google Scholar
• Hsu, M. et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc. Natl Acad. Sci. USA 100, 7271–7276 (2003).
  CAS PubMed PubMed Central Google Scholar
• Yu, M. Y. et al. Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma. Proc. Natl Acad. Sci. USA 101, 7705–7710 (2004).
  CAS PubMed PubMed Central Google Scholar
• Farci, P. et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339–344 (2000).
  CAS PubMed Google Scholar
• Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938–941 (1998).
  CAS PubMed Google Scholar
• Cormier, E. G. et al. CD81 is an entry coreceptor for hepatitis C virus. Proc. Natl Acad. Sci. USA 101, 7270–7274 (2004).
  CAS PubMed PubMed Central Google Scholar
• Kawatani, T. et al. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur. J. Haematol. 67, 45–50 (2001).
  CAS PubMed Google Scholar
• Chazouilleres, O. et al. 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 343, 142–146 (1994).
  CAS PubMed Google Scholar
• Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med. 2, 1104–1108 (1996). This study shows that HBV-specific cytotoxic CD8+ T cells, as well as trace amounts of HBV DNA, co-exist for decades in patients who have clinically recovered from hepatitis B.
  CAS PubMed Google Scholar
• Mizukoshi, E. et al. Cellular immune responses to the hepatitis B virus polymerase. J. Immunol. 173, 5863–5871 (2004).
  CAS PubMed Google Scholar
• Rahman, F. et al. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 31, 521–527 (2000).
  CAS PubMed Google Scholar
• Hollinger, F. B. et al. Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion-transmitted viruses study group. Intervirology 10, 60–68 (1978).
  CAS PubMed Google Scholar
• Lai, M. E. et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343, 388–390 (1994).
  CAS PubMed Google Scholar
• Farci, P. et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 258, 135–140 (1992).
  CAS PubMed Google Scholar
• Mehta, S. H. et al. Protection against persistence of hepatitis C. Lancet 359, 1478–1483 (2002).
  PubMed Google Scholar
• Chen, M. T. et al. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc. Natl Acad. Sci. USA 101, 14913–14918 (2004).
  CAS PubMed PubMed Central Google Scholar
• Whalley, S. A. et al. Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology 127, 1131–1138 (2004).
  PubMed Google Scholar
• Rehermann, B., Pasquinelli, C., Mosier, S. M. & Chisari, F. V. Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96, 1527–1534 (1995).
  CAS PubMed PubMed Central Google Scholar
• Bertoletti, A. et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407–410 (1994).
  CAS PubMed Google Scholar
• Shimizu, Y. K. et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutraliziation escape mutant viruses. J. Virol. 68, 1494–1500 (1994).
  CAS PubMed PubMed Central Google Scholar
• Erickson, A. L. et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15, 883–895 (2001).
  CAS PubMed Google Scholar
• Chang, K. M. et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 100, 2376–2385 (1997).
  CAS PubMed PubMed Central Google Scholar
• Tsai, S. L. et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology 115, 954–965 (1998).
  CAS PubMed Google Scholar
• Frasca, L. et al. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. J. Immunol. 163, 650–658 (1999).
  CAS PubMed Google Scholar
• Seifert, U. et al. Hepatitis C virus mutation affects proteasomal epitope processing. J. Clin. Invest. 114, 250–259 (2004).
  CAS PubMed PubMed Central Google Scholar
• Timm, J. et al. CD8 epitope escape and reversion in acute HCV infection. J. Exp. Med. 200, 1593–1604 (2004).
  CAS PubMed PubMed Central Google Scholar
• Eisen-Vandervelde, A. L. et al. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J. Biol. Chem. 279, 43479–43486 (2004).
  CAS PubMed Google Scholar
• Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J. & Hahn, Y. S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106, 1239–1249 (2000). The first study to show that HCV core protein binds the globular domain of the complement receptor C1q at the surface of T cells and thereby inhibits IL-2 production and T-cell proliferation.
  CAS PubMed PubMed Central Google Scholar
• Large, M. K., Kittlesen, D. J. & Hahn, Y. S. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. J. Immunol. 162, 931–938 (1999).
  CAS PubMed Google Scholar
• Francavilla, V. et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms. Eur. J. Immunol. 34, 427–437 (2004).
  CAS PubMed Google Scholar
• Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nature Med. 8, 379–385 (2002).
  CAS PubMed Google Scholar
• Kanto, T. et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162, 5584–5591 (1999).
  CAS PubMed Google Scholar
• Bain, C. et al. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120, 512–524 (2001).
  CAS PubMed Google Scholar
• Auffermann-Gretzinger, S., Keeffe, E. B. & Levy, S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97, 3171–3176 (2001).
  CAS PubMed Google Scholar
• Dolganiuc, A. et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J. Immunol. 170, 5615–5624 (2003).
  CAS PubMed Google Scholar
• Longman, R. S., Talal, A. H., Jacobson, I. M., Albert, M. L. & Rice, C. M. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103, 1026–1029 (2004).
  CAS PubMed Google Scholar
• Rollier, C. et al. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38, 851–858 (2003).
  CAS PubMed Google Scholar
• Hellier, S. et al. Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 38, 1468–1476 (2003).
  CAS PubMed Google Scholar
• Accapezzato, D. et al. Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113, 963–972 (2004).
  CAS PubMed PubMed Central Google Scholar
• Sugimoto, K. et al. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38, 1437–1448 (2003).
  PubMed Google Scholar
• Cabrera, R. et al. An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40, 1062–1071 (2004).
  CAS PubMed Google Scholar
• Boni, C. et al. Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection. Hepatology 40, 289–299 (2004).
  PubMed Google Scholar
• Rossol, S. et al. Interleukin-12 induction of TH1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Invest. 99, 3025–3033 (1997).
  CAS PubMed PubMed Central Google Scholar
• Tsai, S. L. et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J. Clin. Invest. 89, 87–96 (1992).
  CAS PubMed PubMed Central Google Scholar
• Boni, C. et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 102, 968–975 (1998).
  CAS PubMed PubMed Central Google Scholar
• Boni, C. et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33, 963–971 (2001).
  CAS PubMed Google Scholar
• Boni, C. et al. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J. Hepatol. 39, 595–605 (2003).
  CAS PubMed Google Scholar
• Maini, M. K. et al. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus (HBV) infection. J. Exp. Med. 191, 1269–1280 (2000).
  CAS PubMed PubMed Central Google Scholar
• Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178, 1541–1554 (1993).
  CAS PubMed Google Scholar
• Kakimi, K. et al. Blocking chemokine responsive to γ-2/interferon (IFN)-γ inducible protein and monokine induced by IFN-γ activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194, 1755–1766 (2001).
  CAS PubMed PubMed Central Google Scholar
• Sitia, G. et al. MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J. Clin. Invest. 113, 1158–1167 (2004).
  CAS PubMed PubMed Central Google Scholar
• Liang, T. J. & Heller, T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127, S62–S71 (2004).
  CAS PubMed Google Scholar
• Dammacco, F. et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy. Semin. Liver Dis. 20, 143–157 (2000).
  CAS PubMed Google Scholar
• Zignego, A. L. & Brechot, C. Extrahepatic manifestations of HCV infection: facts and controversies. J. Hepatol. 31, 369–376 (1999).
  CAS PubMed Google Scholar
• Sung, V. M. et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J. Virol. 77, 2134–2146 (2003).
  CAS PubMed PubMed Central Google Scholar
• Machida, K. et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc. Natl Acad. Sci. USA 101, 4262–4267 (2004).
  CAS PubMed PubMed Central Google Scholar
• Day, C. L. et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112, 831–842 (2003).
  CAS PubMed PubMed Central Google Scholar
• Milich, D. R. & McLachlan, A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234, 1398–1401 ( 1986).
  CAS PubMed Google Scholar
• Racanelli, V. & Rehermann, B. Hepatitis C virus infection: when silence is deception. Trends Immunol. 24, 456–464 (2003).
  CAS PubMed Google Scholar